Michael J. Bronskill
Keine laufenden Positionen mehr
Profil
Michael J.
Bronskill was the founder of Profound Medical, Inc. which was founded in 2008, where he held the title of Chief Technology Officer from 2010 to 2011.
He was a former Professor at the University of Toronto and a former Senior Scientist at Sunnybrook Health Sciences Centre from 1990 to 2004.
Dr. Bronskill's education history includes an undergraduate degree, a graduate degree, and a doctorate degree from the University of Toronto.
Ehemalige bekannte Positionen von Michael J. Bronskill
Unternehmen | Position | Ende |
---|---|---|
Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre Hospital/Nursing ManagementHealth Services Sunnybrook Health Sciences Centre owns and manages hospitals. It operates as an academic health sciences center. The firm?s services encompass treating and preventing cancer, cardiovascular disease, neurological disorders, orthopedic and arthritic conditions, and traumatic injuries. It focuses on areas of heart and stroke, cancer, trauma, emergency, and critical care, and women and babies. The firm caters to the war veterans, high risk pregnancies, critically-ill newborns, adults, and the elderly. The company was founded on June 12, 1948 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 01.01.2004 |
University of Toronto | Corporate Officer/Principal | - |
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Gründer | - |
Ausbildung von Michael J. Bronskill
University of Toronto | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |
Sunnybrook Health Sciences Centre
Sunnybrook Health Sciences Centre Hospital/Nursing ManagementHealth Services Sunnybrook Health Sciences Centre owns and manages hospitals. It operates as an academic health sciences center. The firm?s services encompass treating and preventing cancer, cardiovascular disease, neurological disorders, orthopedic and arthritic conditions, and traumatic injuries. It focuses on areas of heart and stroke, cancer, trauma, emergency, and critical care, and women and babies. The firm caters to the war veterans, high risk pregnancies, critically-ill newborns, adults, and the elderly. The company was founded on June 12, 1948 and is headquartered in Toronto, Canada. | Health Services |